| Authors: |
Robertz AS; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Bühnen I; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Meissner J; Medicine V, University of Heidelberg, Heidelberg, Germany., Trautmann-Grill K; Department of Medicine I, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany., Herhaus P; Clinic and Policlinic for Internal Medicine III, Klinikum Rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany., Halbsguth TV; Division of Hematology/Oncology, Department of Medicine II, Goethe University Hospital Frankfurt, Frankfurt, Germany., Schaub V; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Kerkhoff A; Medizinische Klinik A, University Hospital Münster, Münster, Germany., Mathas S; Division of Hematology, Oncology, and Tumor Immunology, Charité Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany., Bormann M; Medical Department I, Klinikum Bremen-Mitte, Bremen, Germany., Dickhut A; Tumorklinik, Klinikum Fulda, Fulda, Germany., Jaworek CP; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Fuchs M; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Kobe C; Department of Nuclear Medicine and German Hodgkin Study Group, University Hospital of Cologne, Cologne, Germany., Baues C; Department of Radiation Oncology and German Hodgkin Study Group, Hospital Bochum, Bochum, Germany., Borchmann P; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., von Tresckow B; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (Partner Site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Behringer K; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Bröckelmann PJ; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany. |
